Press releases
Glycovax Pharma develops a vaccine against COVID-19 – A semi-synthetic vaccine in the preclinical phase
04.21.2020
Download the press release here
Glycovax Pharma Files a Patent Application for a New Semi-Synthetic Vaccine against Breast Cancers
04.04.2018
Download the press release here